Article
Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study.
JCO global oncology - 1 Jun 2021
Gupta Sudeep, Rajappa Senthil, Advani Suresh, Agarwal Amit, Aggarwal Shyam, Goswami Chanchal, Palanki Satya Dattatreya, Arya Devavrat, Patil Shekhar, Kodagali Rohit
Abstract excerpt
PURPOSE: There are deficient data on prevalence of germline mutations in breast cancer susceptibility genes 1 and 2 (BRCA1/BRCA2) in Indian patients with ovarian cancer who are not selected by clinical features. METHODS: This prospective, cross-sectional, noninterventional study in nine Indian centers included patients with newly diagnosed or relapsed epithelial ovarian, primary peritoneal, or fallopian tube...
Topics
- Adult
- Aged
- Aged, 80 and over
- BRCA1 Protein
- BRCA2 Protein
- Cross-Sectional Studies
- Fallopian Tube Neoplasms
- Female
- Humans
- India
